Published by Coherent Market Insights
Posted on October 6, 2021
4 min readLast updated: January 31, 2026
The Diabetes Monitoring Devices market is expected to grow at an 8.87% CAGR by 2027, driven by technological advancements and rising diabetes prevalence.
Diabetes Monitoring Devices Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Diabetes Monitoring Devices Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/1278
Major Players In This Market Are: Bayer Healthcare AG, Medtronic, Dexcom, Sanofi S.A., Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga Medical, and Bigfoot Biomedical.
The rising incidence and prevalence of diabetes owing to changing lifestyles are fostering the growth of the diabetes monitoring devices market. According to the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Of the 34.2 million adults with diabetes, 26.8 million were diagnosed, and 7.3 million were undiagnosed. The growing geriatric population is also increasing prevalence of diabetes which is again augmenting the growth of the market. Furthermore, a growing partnership among key players is another key factor propelling the growth of the diabetes monitoring devices market. For instance, in January 2019, Eris Lifesciences, one of the leading players in the chronic drugs segment, and India Medtronic Pvt. Ltd, a wholly-owned subsidiary of Medtronic plc announced their collaboration for a diabetes monitoring initiative in India.
In November 2020, Abbott announced that the FreeStyle® Libre system, the continuous glucose monitoring (CGM) technology, is now available for adults and children (above the age of four) living with diabetes in India and women with gestational diabetes (diabetes during pregnancy)
In January 2019, The U.S. Food and Drug Administration has approved the first implantable continuous glucose monitoring (CGM) device for people with type 1 and type 2 diabetes. The device, called the Eversense Continuous Glucose Monitoring System, provides monitoring for up to three months, and it’s approved for people age 18 and older
North America is expected to lead the global diabetes monitoring devices market and this is accredited to the growing government initiatives for the prevention of diabetes and treatment support along with the presence of key players in the region. For instance, in April 2017, the Centers for Disease Control and Prevention (CDC) released a five-year funding opportunity announcement to scale up the National Diabetes Prevention Program in underserved areas of the country. Moreover, the CDC’s Division of Diabetes Translation (DDT) funds to state and local health departments to support programs and activities for improving health outcomes in people suffering from diabetes.
Diabetes Monitoring Devices allow Type 1 and Type 2 diabetics to monitor their blood glucose levels from any location, giving them a true sense of independence. They are an easy-to-use, battery-operated, small personal diabetes monitoring device that allows the wearer to remotely monitor his/her blood glucose levels via a Bluetooth interface. This type of device is ideal for people who may not have access to a computer or other source of information, such as those living in rural areas or those with long work hours.
Buy This Premium Report Of Diabetes Monitoring Devices Market Report 2021 @ https://www.coherentmarketinsights.com/insight/buy-now/1278
In this study, the years considered to estimate the market size of Diabetes Monitoring Devices are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Diabetes Monitoring Devices Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Diabetes Monitoring Devices Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Diabetes Monitoring Devices Market Transforming Technology, Industry Size Grows at a 8.87% CAGR, Top Competitive Share, Region Wise Analysis, Upcoming Trends and Forecast To 2027 appeared first on Gatorledger.
The article focuses on the growth and trends of the Diabetes Monitoring Devices market, including technological advancements and regional analysis.
Key drivers include rising diabetes prevalence, technological advancements, and strategic partnerships among key players.
North America is leading the market due to government initiatives and the presence of key industry players.
Explore more articles in the Research Reports category
